Millrace Asset Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-32,253
Closed -$1.17M 74
2021
Q2
$1.17M Sell
32,253
-4,126
-11% -$171K 0.61% 71
2021
Q1
$1.59M Sell
36,379
-4,821
-12% -$226K 0.86% 62
2020
Q4
$1.89M Sell
41,200
-8,274
-17% -$344K 1.32% 39
2020
Q3
$1.64M Buy
+49,474
New +$1.58M 1.33% 33

Other funds holding AVNS

Millrace Asset Group's AVNS Position: Q3 2021 in Review

Millrace Asset Group sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 32,253 shares — an estimated $1.17M sold.

Millrace Asset Group first reported a position in AVNS in Q3 2020 and held it in 4 quarters. The position peaked at $1.89M in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • Millrace Asset Group reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • Millrace Asset Group sold 32,253 Avanos Medical shares in Q3 2021, an estimated $1.17M.
  • Millrace Asset Group first reported a position in Avanos Medical in Q3 2020 and held it in 4 quarters.
  • Millrace Asset Group's Avanos Medical position peaked at $1.89M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on Millrace Asset Group's 13F filing for Q3 2021, filed 12 Nov 2021.